Product Information

IBUPROFEN 200 MG SOFTGEL is a generic product labeled by Rugby Laboratories, priced at $0.0780 per EA under NDC 00536114730. Its NADAC has been published 422 times since Jul 25, 2018.

FDA first approved this application on Jun 21, 2016.

The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

IBUPROFEN 200 MG SOFTGEL

Ibuprofen
$0.0780per EA
High Outlier
OTC

Strength

200 mg/1

Manufacturer

Rugby Laboratories

NDC

00536114730

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA206568

FDA Approved

6/21/2016

On Market Since

2/28/2018

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 200 MG SOFTGEL has been published 422 times since Jul 25, 2018, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0780 per EA
All-time high$0.1178 (Jul 15, 2020)
All-time low$0.0720 (Mar 23, 2022)
52-week high$0.0816
52-week low$0.0780
Median price$0.0830
Average price$0.0865
Largest weekly change+31.0% (Jun 17, 2020)
Weeks tracked422
Tracking sinceJul 25, 2018

Price History

1W

-4.0%

1M

-4.5%

3M

-2.6%

6M

-2.4%

1Y

-2.2%

3Y

-1.2%

5Y

-11.8%

All

-17.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ibuprofen market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of IBUPROFEN 200 MG SOFTGEL?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG SOFTGEL, manufactured by Rugby Laboratories, is $0.0780 per EA (NDC 00536114730), effective Aug 19, 2026.

How has the price of IBUPROFEN 200 MG SOFTGEL changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 200 MG SOFTGEL has declined 17.9%. It has been tracked across 422 weekly CMS publications since Jul 25, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG SOFTGEL?

Since Jul 25, 2018, the NADAC for IBUPROFEN 200 MG SOFTGEL has ranged from a low of $0.0720 (Mar 23, 2022) to a high of $0.1178 (Jul 15, 2020), with a median of $0.0830 per EA.

Are there cheaper alternatives to IBUPROFEN 200 MG SOFTGEL?

No other NADAC-published product currently shares the active ingredient and strength of IBUPROFEN 200 MG SOFTGEL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures IBUPROFEN 200 MG SOFTGEL?

IBUPROFEN 200 MG SOFTGEL (NDC 00536114730) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.